Trial intelligence / Profile preview

Cancer CARE Beyond Walls - In-Home vs In-Clinic Cancer Therapy

NCT07285044Phase 2Recruiting

Sponsor
Mayo Clinic
Start
Dec 2025
Primary completion
May 2027
Countries
1
01

Overview

Phase 2, open-label, single-arm trial in cancer, sponsored by Mayo Clinic. Primary endpoints: Patient preferences regarding location of cancer treatment delivery at 12 weeks, Adverse Events Related to Location of Treatment at 9 months and 1 more. Started Dec 2025; status: recruiting.

02

Conditions

cancer

Beyond the preview

Go deeper on NCT07285044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07285044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call